The distinguishing feature of multiple endocrine neoplasia 2 B (MEN 2B) from multiple endocrine neoplasia 2 A (MEN 2A) is:
**Core Concept**
The multiple endocrine neoplasia (MEN) syndromes are a group of disorders characterized by the occurrence of tumors in multiple endocrine glands. **MEN 2A** and **MEN 2B** are subtypes that primarily affect the thyroid, adrenal, and parathyroid glands, with distinct genetic and clinical features.
**Why the Correct Answer is Right**
MEN 2B is distinguished from MEN 2A by the presence of a **RET proto-oncogene** mutation, leading to a more aggressive form of **medullary thyroid carcinoma (MTC)**, often with an earlier onset, and the presence of **mucosal neuromas** and **marfanoid habitus** without **hyperparathyroidism**. This specific mutation affects the development and function of neural crest-derived cells.
**Why Each Wrong Option is Incorrect**
**Option A:** This choice is incorrect because it does not specifically distinguish MEN 2B from MEN 2A, as both can present with MTC.
**Option B:** Incorrect, as while both MEN 2A and MEN 2B can involve the adrenal glands, the specific distinguishing features of MEN 2B are not related to adrenal pathology alone.
**Option C:** Incorrect, as this option might refer to features that can be present in both conditions or are not the hallmark distinguishing feature of MEN 2B.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that MEN 2B is characterized by the presence of **mucosal neuromas** and a **marfanoid body habitus** in addition to the aggressive form of MTC, which helps in clinically distinguishing it from MEN 2A.
**Correct Answer:** D. presence of mucosal neuromas, marfanoid habitus, and absence of hyperparathyroidism.